<DOC>
	<DOCNO>NCT00457457</DOCNO>
	<brief_summary>This 12 week study different dos formulation UK-369,003 administer patient diagnosis enlarge prostate . Patients complete series questionnaire , treatment assess UK-369,003 improve urinary symptom erectile function . There several blood sample take study asses level drug blood correlate response questionnaire .</brief_summary>
	<brief_title>Study Effects Different Doses UK-369,003 Men With Lower Urinary Tract Symptoms .</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>1 . Male subject age 40 year , document LUTS International Prostate Symptom Score ( IPSS ) ≥13 2 . Clinical diagnosis BPH . 3 . Qmax 5 15ml/sec voided volume ≥150ml visit 1 ( screen ) . 1 . Urinary tract infection 2 . Primary neurological condition affect bladder function</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>With without erectile dysfunction</keyword>
</DOC>